Moderna announced Thursday it will receive up to $54.3 million from a global vaccine partnership to fund its ongoing research into a potential bird flu mRNA vaccine, helping to recover some of the funding that was cut off when the federal government cancelled hundreds of millions in contracts.
About the Author
Discover more from USA NEWS
Subscribe to get the latest posts sent to your email.
